What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Immune system
- Pathology
Philippe Gevaert spends much of his time researching Immunology, Nasal polyps, Immunoglobulin E, Sinusitis and Asthma.
His Immunology research includes themes of Airway, Disease and Microbiology.
His Nasal polyps study is related to the wider topic of Internal medicine.
His Immunoglobulin E study combines topics in areas such as Superantigen, Granulocyte and Atopy.
His Sinusitis research is multidisciplinary, relying on both Evidence-based practice, Position paper and Intensive care medicine.
His Asthma research integrates issues from Nasal spray and Allergy.
His most cited work include:
- European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (1843 citations)
- EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists (1518 citations)
- Differentiation of chronic sinus diseases by measurement of inflammatory mediators. (555 citations)
What are the main themes of his work throughout his whole career to date?
Philippe Gevaert mainly investigates Immunology, Nasal polyps, Immunoglobulin E, Internal medicine and Asthma.
His Immunology research is multidisciplinary, incorporating elements of Disease and Pathology.
His research in Nasal polyps intersects with topics in Chronic rhinosinusitis, Surgery, Sinusitis, Dupilumab and Omalizumab.
His Immunoglobulin E research focuses on Interleukin 5 and how it relates to Eosinophil.
His research investigates the link between Internal medicine and topics such as Placebo that cross with problems in Nasal congestion.
He studied Asthma and Intensive care medicine that intersect with Position paper.
He most often published in these fields:
- Immunology (47.77%)
- Nasal polyps (36.16%)
- Immunoglobulin E (25.00%)
What were the highlights of his more recent work (between 2018-2021)?
- Nasal polyps (36.16%)
- Chronic rhinosinusitis (15.18%)
- Internal medicine (19.64%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Nasal polyps, Chronic rhinosinusitis, Internal medicine, Asthma and Omalizumab.
His study in Nasal polyps is interdisciplinary in nature, drawing from both Mepolizumab, Surgery, Sinusitis, Adverse effect and Dupilumab.
He interconnects Dermatology, Sinus and Otorhinolaryngology in the investigation of issues within Chronic rhinosinusitis.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Placebo.
His work deals with themes such as Pharmacy, Chronic inflammatory disease, Allergy and Intensive care medicine, which intersect with Asthma.
His Allergy study is focused on Immunology in general.
Between 2018 and 2021, his most popular works were:
- European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (1843 citations)
- Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. (50 citations)
- The role of mobile health technologies in allergy care: An EAACI position paper (35 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Immune system
- Pathology
Nasal polyps, Intensive care medicine, Asthma, Allergy and Omalizumab are his primary areas of study.
His work carried out in the field of Nasal polyps brings together such families of science as Paranasal sinuses, Chronic rhinosinusitis, Surgery, Sinusitis and Dupilumab.
His Intensive care medicine research includes elements of Disease susceptibility, Position paper, Evidence-based medicine and Asthma therapy.
The concepts of his Asthma study are interwoven with issues in Allergen immunotherapy, Quality of life, Airborne allergen and Reimbursement.
Philippe Gevaert has researched Allergy in several fields, including Adverse effect and Disease.
The various areas that Philippe Gevaert examines in his Omalizumab study include Quality of life, Placebo, Double blind, Medical physics and Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
